Optimal levels of parenteral nutrition (PN) in the catabolic patient

ISRCTN ISRCTN44082375
DOI https://doi.org/10.1186/ISRCTN44082375
Secondary identifying numbers N0231150767
Submission date
30/09/2005
Registration date
30/09/2005
Last edited
18/07/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Mike Stroud
Scientific

Institute of Human Nutrition
West Wing, Level C
Southampton General Hospital
Tremona Road
Southampton
SO16 6YD
United Kingdom

Phone +44 (0)1703 796317
Email M.A.Stroud@soton.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use contact details to request a participant information sheet
Scientific titleOptimal levels of parenteral nutrition (PN) in the catabolic patient
Study objectivesTo determine whether intravenous provision of nutrition at levels lower than those currently recommended in guidelines from the British Association of Parenteral and Enteral Nutrition (BAPEN) decrease PN related complications and are beneficial to clinical outcome.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedParenteral nutrition
InterventionA double blind, randomised trial of parenteral nutrition (PN) support during the first five days of feeding at around the mid-range of current BAPEN recommendations (30 Kcal/kg non-protein energy + 0.25 gN/kg) VS. levels equating the minimum 'maintenance' feeding for a healthy resting individual (15 Kcal/kg non-protein energy + 0.125 gN/kg)
Intervention typeOther
Primary outcome measure1. Anthropometric changes
2. Haematological and biochemical disturbances
3. Clinical outcomes - infections, fluid balance and oedema, duration of PN, length of hospital stay, and mortality
Secondary outcome measuresNot provided at time of registration
Overall study start date01/02/2004
Completion date01/06/2005

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants100
Key inclusion criteriaAll consenting adults requiring PN, who do not require specialised regimes to meet their clinical needs. Preliminary analysis of the data will be undertaken once 50 subjects are recruited to each arm.
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/02/2004
Date of final enrolment01/06/2005

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Southampton General Hospital
Southampton
SO16 6YD
United Kingdom

Sponsor information

Department of Health
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

Southampton University Hospitals NHS Trust (UK)

No information available

NHS R&D Support Funding (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

18/07/2016: No publications found, verifying study status with principal investigator.